Sy Mukherjee, Fortune

Sy Mukherjee


New York, NY, United States

Contact Sy

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Start free trial

  • Fortune

Recent articles by Sy:

COVID-19 and diabetes: Can the coronavirus cause diabetes? Here's what we know

We know that people with diabetes are at higher risk for COVID-19. But mounting evidence suggests coronavirus can actually cause patients to get diabetes, too. → Read More

How chief health officers could help campuses navigate COVID

An unprecedented pandemic requires experts on college campuses who can traverse medical, epidemiological, social, and logistical issues all at the same time. → Read More

These cofounders believe sewage is the key to tracking COVID

How one company's wastewater analytics technology can identify upcoming COVID-19 outbreaks. → Read More

The myth—and danger—of COVID herd immunity

The Trump administration is reportedly embracing herd immunity to fight COVID-19. Scientists say that would be a tragic and dangerous mistake. → Read More

Last night’s debate ignored some critical health care issues

Last night's vice presidential debate between Mike Pence and Kamala Harris featured health care—but missed many of the key points. → Read More

COVID treatments like the experimental antibody therapeutic Trump received are making progress

The cool science behind Regeneron's and now Eli Lilly's monoclonal antibody cocktail drugs could ramp up the fight against COVID-19. → Read More

Trump wants a COVID vaccine before Election Day, but fewer Americans are saying they’ll get one

New polling shows that a smaller percentage of Americans are saying they'll get a coronovirus vaccine when one is released. → Read More

How President Trump got special access to his coronavirus treatment

A hospitalized President Trump got special access to his COVID treatment through an obscure FDA regulatory process. → Read More

Trump is being treated with a COVID drug that wasn't one of the questionable therapies he's previously touted

President Trump has touted dubious cures for the coronavirus. Now that he's been hospitalized with COVID, he's not taking them. → Read More

Bristol Myers Squibb and Celgene got a beating in Congress on drug prices—but only Congress can fix the problem

Drug price hikes will never go down until Congress takes action. → Read More

Articles by Sy Mukherjee

© 2020 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell My Info | Ad Choices FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website.… → Read More

Trump-Biden debate: Trump's 4 biggest lies about health care from first presidential debate

President Trump and former Vice President Joe Biden sparred over healthcare in the first 2020 presidential debate—and it was filled with falsehoods from Trump. → Read More

How 3 of biopharma's most powerful women are building public trust during COVID

From testing to vaccines, drug and diagnostics giants have to gain the trust of the public to quell the coronavirus pandemic. → Read More

The world is obsessed with new COVID drugs. But other important treatments are in the works, too

Coronavirus treatments are critical. But drug development for Alzheimer's and other critical therapies for mental illnesses are also important. → Read More

COVID and the flu present a clash of viruses

What happens when COVID mashes up against the flu season? → Read More

Coronavirus vaccine: Where the 4 major COVID vaccines currently stand

There are four major potential COVID vaccines in late-stage trials now. Here's how they stack up. → Read More

Eli Lilly is teaching an old drug technology new tricks against COVID—and has promising early results

Eli Lilly has announced the first set of truly (if early) promising results for a monoclonal antibody to reduce the risk of hospitalization for COVID. → Read More

Even the most cautious schools are seeing outbreaks

"The question will be: Will they be small and manageable and they can go on, or will you have to shut down and go online indefinitely?" → Read More

Restaurant dining is making the COVID crisis worse: CDC

A new CDC report finds that people who contracted COVID were twice as likely to say that they'd recently dined indoors at restaurants. → Read More

The rollercoaster of COVID-19 vaccines

AstraZeneca's road bump, optimism from Pfizer, and other tales from the quest for a coronavirus vaccine. → Read More